Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Ianalumab[1] Ianalumab (Ianalumab)[1] Ianalumab (Ianalumab) 💬 [1] TNFRSF13C 💬 [5] Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬[8] 35, 46, 49, 51, 53, 61, 63, 95 💬
2Ianalumab (VAY736)[1] Ianalumab (Ianalumab)[1] Ianalumab (Ianalumab) 💬 [1] TNFRSF13C 💬 [5] Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬[1] 53 💬
3IanalumabProduct Code: VAY736Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: IanalumabCurrent Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous use----[2] 61, 63 💬
4IanalumabProduct Code: VAY736Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: IANALUMABCAS Number: 1929549-92-7Current Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use----[1] 53 💬